What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.46%
Annual Rate
CNY 0.02Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jun 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.34BCNY
497.65M · vs all stocks (USD)
Updated Sep 19, 2026
Revenue (TTM)
2.21BCNY
329.89M · vs all stocks (USD)
Updated Sep 19, 2026
Profit Margin
-0.94%
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Beta
0.3080x
vs all stocks
Updated Sep 19, 2026
52-Week Change
-13.48%
vs all stocks
Updated Sep 19, 2026
Forward Annual Dividend Yield
0.46%
vs all stocks
Updated Sep 19, 2026
Market Capitalization
3.34BCNY
497.65M · vs all stocks (USD)
Updated Sep 19, 2026
Enterprise Value
4.49BCNY
670.20M · vs all stocks (USD)
Updated Sep 19, 2026
Price to Sales (TTM)
1.50x
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Price to Book (MRQ)
2.09x
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Enterprise to Revenue
2.03x
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Enterprise to EBITDA
22.33x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 13.6×.Updated Sep 19, 2026
Gross Margin
45.84%
vs Medical Instruments & Supplies peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 52.86%.Updated Sep 19, 2026
Profit Margin
-0.94%
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Operating Margin
4.10%
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Return on Assets (TTM)
1.44%
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Return on Equity (TTM)
-0.70%
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Revenue (TTM)
2.21BCNY
329.89M · vs all stocks (USD)
Updated Sep 19, 2026
Revenue per Share (TTM)
2.94CNYUpdated Sep 19, 2026
Quarterly Revenue Growth
-14.00%
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Gross Profit (TTM)
1.17BCNY
174.38M · vs all stocks (USD)
Updated Sep 19, 2026
EBITDA (TTM)
330.33MCNY
49.27M · vs all stocks (USD)
Updated Sep 19, 2026
Net Income (TTM)
-20.72MCNY
-3.09M · vs all stocks (USD)
Updated Sep 19, 2026
Quarterly Earnings Growth (YoY)
-14.05%
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Operating Cash Flow (TTM)
142.22MCNY
21.21M · vs all stocks (USD)
Updated Sep 19, 2026
Levered Free Cash Flow (TTM)
112.09MCNY
16.72M · vs all stocks (USD)
Updated Sep 19, 2026
Forward Annual Dividend Rate
0.0200CNYUpdated Sep 19, 2026
Forward Annual Dividend Yield
0.46%
vs all stocks
Updated Sep 19, 2026
Trailing Annual Dividend Rate
0.0200CNYUpdated Sep 19, 2026
Trailing Annual Dividend Yield
0.46%
vs all stocks
Updated Sep 19, 2026
Payout Ratio
0.00%
vs Medical Instruments & Supplies peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -66.67%.Updated Sep 19, 2026
Minority Interest (Equity)
219.87MCNYFY2025 · Dec 31, 2025
Revenue
2.44BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
995.34MCNYFY2025 · Dec 31, 2025
Gross Profit
1.45BCNYFY2025 · Dec 31, 2025
Operating Income
176.90MCNY
26.39M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
105.63MCNYFY2025 · Dec 31, 2025
Income Tax Expense
44.21MCNYFY2025 · Dec 31, 2025
Net Income
61.42MCNYFY2025 · Dec 31, 2025
EBIT
154.67MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
330.33MCNYFY2025 · Dec 31, 2025
Research & Development
100.68MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
903.18MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
34.67MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
245.13KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
49.04MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0636CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0636CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
752.92MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
752.92MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
61.42MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-13.54MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
252.80MCNYFY2025 · Dec 31, 2025
Free Cash Flow
153.64MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
133.32MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
61.42MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
87.81MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
76.39MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
27.18MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-99.16MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-20.02MCNYFY2025 · Dec 31, 2025
Sale of Investments
22.00MCNYFY2025 · Dec 31, 2025
Other Investing Activity
3.80KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-97.18MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
551.10MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-468.25MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-4.91MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-2.26MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
75.69MCNYFY2025 · Dec 31, 2025
Shares Outstanding
753.13MSharesUpdated Sep 19, 2026
Float Shares
505.99MSharesUpdated Sep 19, 2026
% Held by Insiders
35.91%
vs all stocks
Updated Sep 19, 2026
% Held by Institutions
0.39%
vs all stocks
Updated Sep 19, 2026
Total Cash (MRQ)
168.21MCNY
25.09M · vs all stocks (USD)
Updated Sep 19, 2026
Total Cash per Share (MRQ)
0.2230CNYUpdated Sep 19, 2026
Total Debt (MRQ)
1.14BCNY
169.98M · vs all stocks (USD)
Updated Sep 19, 2026
Total Debt to Equity (MRQ)
0.6283x
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Current Ratio (MRQ)
1.14x
vs Medical Instruments & Supplies peers
Updated Sep 19, 2026
Book Value per Share (MRQ)
2.11CNYUpdated Sep 19, 2026
Total Assets
4.00BCNY
596.93M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.69BCNYFY2025 · Dec 31, 2025
Total Liabilities
2.15BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.31BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
671.86MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.47BCNYFY2025 · Dec 31, 2025
Cash
133.32MCNYFY2025 · Dec 31, 2025
Cash Equivalents
5.74MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
139.06MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
1.76MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.04BCNYFY2025 · Dec 31, 2025
Inventory
186.94MCNYFY2025 · Dec 31, 2025
Accounts Payable
448.26MCNYFY2025 · Dec 31, 2025
Short-term Debt
642.64MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
9.78MCNYFY2025 · Dec 31, 2025
Long-term Debt
484.56MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
753.13MCNYFY2025 · Dec 31, 2025
Retained Earnings
501.62MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.86BCNY
276.74M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
3.76CNYUpdated Sep 19, 2026
52-Week High
5.96CNYUpdated Sep 19, 2026
52-Week Change
-13.48%
vs all stocks
Updated Sep 19, 2026
Beta
0.3080x
vs all stocks
Updated Sep 19, 2026
50-Day MA
4.43CNYUpdated Sep 19, 2026
200-Day MA
4.74CNYUpdated Sep 19, 2026
Avg 10-Day Volume
22.99MSharesUpdated Sep 19, 2026
Avg 30-Day Volume
45.14MSharesUpdated Sep 19, 2026
Diluted EPS (TTM)
-0.0300CNYUpdated Sep 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.46Profit Margin: -0.01
Financial Health
Altman Z-Score 1.91: grey zoneSignificant
Altman Z-Score: 1.91
High earnings qualityNotable
Earnings Quality Score: 2.04
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.